70 percet and less dossed patients. $TLTFF I'm expecting the number to come up slowly. The first dozen patients treated on the first round at a low dose. Now the full-strength data is coming in and the 70% dozen patients are of course in the numbers too. I'm expecting it to increase modestly as the study is now starting to show full strength data.
67% CR in Phase one study at 18 months on one full dose treatment. Patients were released from the study at 18 months. But the doctor knows his patient and only they know the 24 mo. results.
But Principal Investigator After all that set the first 12 patients in the phase 2 PIVATOL at about 70 percent dose. I think he had in mind not to over treat AND to mop up the second treatment at full dose.